Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
asthma
MedTech
Spiro Medical snares $67M series A funding for asthma treatment
Spiro Medical, which debuted last year, reeled in $67 million in series A funding it plans to use to develop its novel treatment for asthma.
Joseph Keenan
Jan 8, 2026 10:50am
Foresee offloads clinical-stage MMP-12 inhibitors in $584M deal
Jan 8, 2026 7:45am
Windward pens $700M deal for Qyuns' immunology bispecific
Dec 22, 2025 7:40am
2 biotechs run out of road
Dec 17, 2025 11:38am
Roche pens $1B deal for respiratory bispecific from China
Oct 30, 2025 5:04am
Areteia posts ph. 3 asthma win for oral rival to biologic drugs
Sep 16, 2025 9:20am
